Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental amphotericin B poisoning |
Causative agent (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional amphotericin B poisoning |
Causative agent (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par l'amphotéricine B d'intention indéterminée |
Causative agent (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B measurement |
Has measured component |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin measurement (procedure) |
Has measured component |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by amphotericin B |
Causative agent (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B measurement |
Component |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin measurement (procedure) |
Component |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin b 50mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin b 100mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin b 50mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin b 100mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin b 5mg/mL infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B liposome (substance) |
Is a |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental amphotericin B poisoning |
Causative agent (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional amphotericin B poisoning |
Causative agent (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B cholesteryl sulfate complex |
Is a |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B lipid complex |
Is a |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional amphotericin B overdose (disorder) |
Causative agent (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental amphotericin B overdose |
Causative agent (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B overdose |
Causative agent (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose d'amphotéricine B d'intention indéterminée |
Causative agent (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin b 50mg infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amphotericin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amphotericin B in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amphotericin B in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B cholesteryl sulfate complex |
Is modification of (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B lipid complex |
Is modification of (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B liposome (substance) |
Is modification of (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
Has precise active ingredient |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B phospholipid complex (substance) |
Is modification of (attribute) |
False |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 50mg i-v infusion (pdr for recon) (product) |
Has basis of strength substance (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin 50mg i-v infusion (pdr for recon) (product) |
Has precise active ingredient |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amphotericin B in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin B in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin B in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin B in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has precise active ingredient |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amphotericin B (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |